FDA Grants Marketing of New Device for Continuous Dialysis Therapy for use in Pediatric Patients with Certain Kidney Conditions
The new Dialysis Therapy device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms (or 5.5 to 22 pounds).
Dr Peter Meintjes joins Transplant Genomics as CCO
Dr Peter Meintjes joins TGI after six years at Omixon, a world leader in pre-transplant HLA Typing, where he departs as CEO, having grown the company at a CAGR of >75% since its first full year of operation as a molecular diagnostics company.
FDA Grants Hardy Diagnostics Emergency Use Authorization for a Rapid Antibody Test Kit for COVID-19
This immunoassay is intended for qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human plasma or serum notes Hardy Diagnostics.
National Launch of the ShurFit 2C Interbody Systems Featuring Titanium Plasma Spray and Hydroxyapatite Coating
“The ShurFit 2C Interbody Systems distinguishing feature is its unique coating of both Titanium and Hydroxyapatite that helps increase durability and makes enhanced fixation possible while the process of biologic fusion takes place,” said Stephen D. Cook, Ph.D.
Frost & Sullivan Presents the Unprecedented Opportunities in the Personal Protection Equipment Industry
Frost & Sullivan invites you to join Global President & Managing Partner Aroop Zutshi and Vice President Sanjiv Bhaskar for the Growth Opportunity briefing, "COVID-19: Growth Opportunities in the PPE Industry," on May 7 at 11 a.m. EST.